Patents by Inventor Bernard Charles Sherman

Bernard Charles Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 11723874
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: August 15, 2023
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 11607389
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: March 21, 2023
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 11458103
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: October 4, 2022
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20220265559
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: May 12, 2022
    Publication date: August 25, 2022
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 11357731
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: June 14, 2022
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20210386677
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: May 21, 2021
    Publication date: December 16, 2021
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 10940116
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: March 9, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 10940115
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: March 9, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 10780055
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: September 22, 2020
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20200268672
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20200253945
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: October 25, 2018
    Publication date: August 13, 2020
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20200237674
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 30, 2020
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20200188309
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20190125682
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: October 25, 2018
    Publication date: May 2, 2019
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
    Publication number: 20190117581
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Application
    Filed: October 25, 2018
    Publication date: April 25, 2019
    Inventors: Bernard Charles SHERMAN, Michael SPINO
  • Meloxicam Dosage Forms
    Publication number: 20180168932
    Abstract: The present invention relates to a process of manufacture of dosage forms for oral administration of meloxicam, or a salt thereof.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 21, 2018
    Inventor: Bernard Charles Sherman
  • Diclofenac Dosage Forms
    Publication number: 20180168933
    Abstract: The present invention relates to oral dosage forms of diclofenac, and processes for their manufacture, that provide a rapidly absorbed dose of diclofenac without requiring milling of diclofenac to submicron sizes.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 21, 2018
    Inventor: Bernard Charles Sherman
  • Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
    Publication number: 20170056341
    Abstract: An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided is a method for the preparation of the improved extended release capsule of cyclobenzaprine.
    Type: Application
    Filed: February 22, 2016
    Publication date: March 2, 2017
    Inventor: Bernard Charles Sherman
  • Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
    Publication number: 20170056342
    Abstract: An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided is a method for the preparation of the improved extended release capsule of cyclobenzaprine.
    Type: Application
    Filed: August 31, 2015
    Publication date: March 2, 2017
    Inventor: Bernard Charles Sherman
  • Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride
    Publication number: 20170056343
    Abstract: An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided is a method for the preparation of the improved extended release capsule of cyclobenzaprine.
    Type: Application
    Filed: July 14, 2016
    Publication date: March 2, 2017
    Inventor: Bernard Charles Sherman